Form 8-K - Current report:
SEC Accession No. 0001493152-25-008617
Filing Date
2025-02-28
Accepted
2025-02-28 08:00:34
Documents
15
Period of Report
2025-02-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40820
2 ex99-1.htm EX-99.1 10036
3 ex99-1_001.jpg GRAPHIC 4489
  Complete submission text file 0001493152-25-008617.txt   232216

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aim-20250226.xsd EX-101.SCH 3015
5 XBRL LABEL FILE aim-20250226_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE aim-20250226_pre.xml EX-101.PRE 22360
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3567
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 25682784
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)